Asia outlook from The Economist / Biotech in China

Selected quotes from The Economist’s latest survey of company executives (mostly from North America and Europe) about their outlook for doing business in Asia, Investing in an accelerating Asia? (37-p PDF).

After a slowdown in 2012, executives expect better things in 2013

Companies are expecting their sales to grow twice as fast as the size of their workforce

China and India remain the top two investment destinations. Indonesia is a close third, while Vietnam has lost its shine

The share of global revenues coming from Asia Pacific for multinational firms is rising at warp speed

Western firms change the way they organize themselves in Asia

Companies are relocating their operations more frequently today than in the past

Another note on business in China, from Bioscience Technology – China to Boost Biotech Industry :

The Chinese government will give a boost to the biotechnology industry … The government aims to double the share of GDP that the sector’s value-added output accounts for by 2015 from the 2010 level, according to a biotech industry development plan unveiled by the State Council, or China’s cabinet.

The sector will see its output surge at an average annual rate of more than 20 percent from 2013 to 2015, according to the plan.